SPELEO-KINESIOTHERAPY

Por Neli Claudia Bîlha, Ştefan Bîlha, Andrei Bîlha
Publicado em 2019-01-01

The balneary treatment course – A BREATH OF LIFE

Por Bilha Neli-Claudia, Bilha Stefan
Publicado em 2015-09-01

ACUTE POSTERIOR MULTIFOCAL PLACOID PIGMENT EPITHELIOPATHY FOLLOWING INFLUENZA VACCINATION

Por Branisteanu, Daniel, Bilha, Andrei
Publicado no Rom J Ophthalmol (2015)

Endogenous Dark Respiration of the Blue-Green Alga, Plectonema boryanum

Por Padan, Etana, Raboy, Bilha, Shilo, Moshe
Publicado em 1971

Aflibercept efficacy in refractory choroidal neovascularization

Por Brănişteanu, Daniel Constantin, Bîlhă, Andrei, Moraru, Andreea
Publicado no Rom J Ophthalmol (2016)

Vitrectomy surgery of diabetic retinopathy complications

Por Constantin, Brănişteanu Daniel, Andrei, Bilha, Andreea, Moraru
Publicado no Rom J Ophthalmol (2016)

Anatomical results and complications after silicone oil removal

Por Brănişteanu, Daniel Constantin, Moraru, Andreea, Bîlha, Andrei
Publicado no Rom J Ophthalmol (2017)

VARIATIONS OF ADIPOKINE PROFILE IN PATIENTS DIAGNOSED WITH RECTAL CARCINOMA

Por Florescu, A., Bilha, S., Grigoras, I., Branisteanu, D.
Publicado no Acta Endocrinol (Buchar) (2019)

Enhancement of Resistance to Infectious Diseases by Oral Administration of Brewer's Yeast

Por Sinai, Yehudith, Kaplun, A., Hai, Y., Halperin, Bilha
Publicado em 1974

Structure and ligand-binding site characteristics of the human P2Y(11) nucleotide receptor deduced from computational modelling and mutational analysis

Por Zylberg, Jacques, Ecke, Denise, Fischer, Bilha, Reiser, Georg
Publicado em 2007

“Cleavable Trifunctional” Approach to Receptor Affinity Labeling: Chemical Regeneration of Binding to A(1)-Adenosine Receptors

Por Jacobson, Kenneth A., Fischer, Bilha, Ji, Xiao-duo
Publicado em 1995

MOLECULAR PROBES FOR MUSCARINIC RECEPTORS: FUNCTIONALIZED CONGENERS OF SELECTIVE MUSCARINIC ANTAGONISTS

Por Jacobson, Kenneth A., Fischer, Bilha, van Rhee, A. Michiel
Publicado em 1995

Boranophosphate Isoster Controls P2Y-Receptor Subtype Selectivity and Metabolic Stability of Dinucleoside Polyphosphate Analogues

Por Yelovitch, Shir, Camden, Jean, Weisman, Gary A., Fischer, Bilha
Publicado no J Med Chem (2011)

Cancer therapeutic antibodies come of age: Targeting minimal residual disease

Por Ben-Kasus, Tsipi, Schechter, Bilha, Sela, Michael, Yarden, Yosef
Publicado no Mol Oncol (2007)

Thyrotoxic Periodic Paralysis—A Misleading Challenge in the Emergency Department

Por Stefana Bilha, Ovidiu Mitu, Laura Teodoriu, Cristian Haba, Cristina Preda
Publicado em 2020-05-01

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: Relevance of receptor endocytosis

Por Ben-Kasus, Tsipi, Schechter, Bilha, Lavi, Sara, Yarden, Yosef, Sela, Michael
Publicado em 2009

Thrombin Aptamer-Modified Metal–Organic Framework Nanoparticles: Functional Nanostructures for Sensing Thrombin and the Triggered Controlled Release of Anti-Blood Clotting Drugs

Por Chen, Wei-Hai, Karmi, Ola, Willner, Bilha, Nechushtai, Rachel, Willner, Itamar
Publicado no Sensors (Basel) (2019)

O Capital Social na Microrregião de Toledo-Pr

Por Lucir Reinaldo Alves, Lizandra Bilha Cruz, Jandir Ferrera de Lima, Moacir Piffer
Publicado em 2013-01-01

Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth

Por Mahlknecht, Georg, Maron, Ruth, Mancini, Maicol, Schechter, Bilha, Sela, Michael, Yarden, Yosef
Publicado em 2013

Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2

Por Maron, Ruth, Schechter, Bilha, Mancini, Maicol, Mahlknecht, Georg, Yarden, Yosef, Sela, Michael
Publicado em 2013